J. Kilian Mellon - Concepedia

Author

J. Kilian Mellon

Also Known As

J K Mellon, J Kilian Mellon, J. K. Mellon, J. KILIAN MELLON, J. Kilian Mellon, J. Mellon, J.K Mellon, J.K. Mellon, J.Kilian Mellon, JK Mellon

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Newcastle University University of Leicester Leicester General Hospital Freeman Hospital Leicester Royal Infirmary

About

J. Kilian Mellon is an author at Newcastle University specializing in urology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	340
2	Cell Biology	4	4	144
3	Engineering	1	1	39
4	Chemical Engineering	1	1	39
5	Chemistry	1	1	39

J. Kilian Mellon

Publications

762

Citations

H-Index

Page 1

	Year	Citations
C-ERBB-2 in Bladder Cancer: Molecular Biology, Correlation with Epidermal Growth Factor Receptors and Prognostic Value J. Kilian Mellon, John Lunec, Chris Wright, The Journal of Urology	1996	117
Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67 V M Tut, Kerynne L. Braithwaite, Bill Angus, British Journal of Cancer	2001	82
Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity MANAR A.L. MONEEF, Benedict T. Sherwood, Karen J. Bowman, British Journal of Cancer Tumor BiologyUrologyRadiation TherapyGenitourinary CancerMedicine	2003	66
NEURAL NETWORK ANALYSIS OF CLINICOPATHOLOGICAL AND MOLECULAR MARKERS IN BLADDER CANCER Khaver Qureshi, R.N.G. Naguib, Freddie C. Hamdy, The Journal of Urology	2000	62
Combined Treatment of Bladder Cancer Cell Lines with Lapatinib and Varying Chemotherapy Regimens—Evidence of Schedule-Dependent Synergy Lynsey A. McHugh, Marina Kriajevska, J. Kilian Mellon, Urology Schedule-dependent SynergyUrologyGenitourinary CancerMedicineCancer Cell Biology	2007	54
Gefitinib (‘Iressa’, ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2 J E Nutt, H P Lazarowicz, J. Kilian Mellon, British Journal of Cancer	2004	53
A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinoma. Rosalyn M. Adam, Theodora Danciu, Dawn L. McLellan, PubMed Human GrowthPathologyCell ProliferationCancer BiologyTumor Biology	2003	48
Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer. Garrett Durkan, J E Nutt, Colin Marsh, PubMed	2003	44
Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor J. Kilian Mellon, Susan Cook, P. L. Chambers British Journal of Cancer Tumor BiologyUrologyGenitourinary CancerMedicineGrowth Factor Receptor	1996	43
Preparation of hydrosol suspensions of elemental and core–shell nanoparticles by co-deposition with water vapour from the gas-phase in ultra-high vacuum conditions C. Binns, P. Prieto, S.H. Baker, Journal of Nanoparticle Research Materials ScienceColloid ChemistryChemical EngineeringColloidal MaterialEngineering	2012	39

Page 1